Symbols

PRCT

PROCEPT BioRobotics·NASDAQ

--(--)

PRCT fundamentals

PRCT Q4 2025 Earnings

PROCEPT BioRobotics (PRCT) released its earnings on Feb 25, 2026: revenue was 76.38M (YoY +11.94%), missed estimates; EPS was -0.53 (YoY -51.43%), missed estimates.

Revenue / YoY

76.38M

+11.94%

EPS / YoY

-0.53

-51.43%

Report date

Feb 25, 2026

PRCT Earnings Call Summary for Q4,2025

Pricing Discipline Wins: Ended bulk discounts, driving 5% QoQ ASP increase to $3,340. 2026 ASP target $3,500 reflects sustained discipline.
Structural Changes Pay Off: Launch team and regional alignment expected to accelerate procedure growth, with Q4 2025 procedures up 69% YoY.
Guidance Reset: 2026 revenue $390-410M (27-33% growth), with Q4 EBITDA positive at both ends of range.
Focus on Utilization: 1:1 handpiece-procedure ratio eliminates inventory volatility, aligning revenue with clinical activity.
Long-Term Vision: 2026 U.S. procedures 60,000-64,000 (39-48% growth), driven by new system placements and improved launch execution.

Earnings

EPS

Revenue

Revenue & Expenses

PRCT has released its 2025 Q4 earnings report, with revenue of 76.38M, reflecting a YoY change of 11.94%, and net profit of -29.84M, showing a YoY change of -58.28%. The Sankey diagram below clearly presents PRCT's revenue sources and cost distribution.

Key Indicators

PROCEPT BioRobotics (PRCT) key financial stats and ratios, covering profitability, financial health, and leverage.

Income Statement

PROCEPT BioRobotics (PRCT)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.

Trend

Breakdown

Balance Sheet

PROCEPT BioRobotics (PRCT)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.

Trend

Breakdown

Cash Flow

PROCEPT BioRobotics (PRCT)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.

Trend

Breakdown